Notice of Intent: Chromium GEM-X sequencing reagents

Description: The National Institutes of Health intends to award a firm-fixed-price purchase order to 10X Genomics, Inc. for Chromium GEM-X sequencing reagents supporting a Gulf War Illness patient study conducted by the National Institute of Neurological Disorders and Stroke (NINDS). The reagents will be used to prepare gene-expression, T-cell-receptor, and B-cell-receptor libraries for single-cell sequencing and subsequent analysis, with consistent experimental protocols maintained for ongoing research. This is an open federal procurement presolicitation—not a grant program—with a small-business set-aside for performance in Bethesda, Maryland; capability statements are due September 10, 2026, at 3:00 p.m. EDT.